Timing Management for Gastric Cancer Patients During the COVID-19 Pandemic

Managing medical appointments is a major concern for gastric cancer patients during the ongoing pandemic. While it's natural to feel anxious and want immediate care, the majority of gastric cancer treatments are classified as time-sensitive rather than emergency procedures. This means that while timely treatment is crucial, certain delays may be acceptable depending on the stage and condition of the disease.

Understanding the stage of gastric cancer is key to determining the appropriate timing for treatment. Here are some general guidelines based on clinical scenarios:

For early-stage gastric cancer, which tends to progress slowly, a delay of up to six months before surgery typically does not have a significant impact on long-term survival outcomes. This allows patients some flexibility in scheduling procedures while still maintaining optimal health outcomes.

In the case of locally advanced gastric cancer, often referred to as mid-stage cancer, a waiting period of 1 to 3 months before surgery is generally acceptable. For patients undergoing neoadjuvant chemotherapy, the interval between the last chemotherapy session and surgery should ideally not exceed 5 to 6 weeks. Meanwhile, for those receiving adjuvant chemotherapy after a curative surgery, treatment can be initiated around 3 to 4 weeks post-operation and may be extended up to 6 to 8 weeks if necessary.

For advanced or metastatic gastric cancer, a delay of up to two weeks for chemotherapy is generally considered safe and acceptable, provided the patient's condition remains stable.

However, in cases of gastric cancer complicated by bleeding or obstruction, prompt emergency care is strongly recommended. These symptoms can be life-threatening and should not be postponed.

In normal circumstances, gastric cancer treatment follows a time-sensitive approach where earlier intervention is usually better. However, during the unique challenges of the pandemic, limited and strategic delays may be considered based on individual patient conditions. It is always best to consult with a specialist to make an informed and personalized decision regarding your treatment timeline.